Xijia Medical, a brain science-focused AI enterprise, has recently successfully closed its Pre-A funding round, raising tens of millions of yuan. The round was spearheaded by China National Capital, with significant participation from Wuxi Innovation Investment, Qinzhicapital, Huichuang Medical, and Prosperity Capital. The fresh capital injection will be earmarked for advancing clinical research endeavors, fueling market expansion strategies, and driving product iteration and innovation.
